Two patients with thalassemia minor and end-stage renal failure on hemodialysis were treated with epoetin zeta (Silapo, Retacrit; STADA, Germany), a medicinal product that was developed and registered as biosimilar to epoetin alfa. Dosing was titrated individually for two patients to achieve a ...
Brand name Eprex®/Erypo® Binocrit®/Abseamed®/epoetin alfa HEXAL® Retacrit®/Silapo® Non-branded descriptor – HX575 SB309 INN Epoetin alfa Epoetin alfa Epoetin zeta EC approval date Jun 1989 Aug 2007 Dec 2007 FDA approval Feb 1999 (Epogen®/Procrit®) – May 2018 (Ret...
The PASCO II study (post-authorization safety cohort observation of Retacrit and Silapo (epoetin-味) administered subcutaneously for the treatment of renal anemia) followed 6,346 patients (4,501 Retacrit (group R); 1,845 Silapo (group S)) for up to 3 years of subcutaneous treatment with ...